Description

Ornidazol (ornidazol) Coated Tablets 0.5 g. №10

Ingredients

Ornidazol (ornidazol) 0.5 g per coated tablet, along with inactive ingredients.

Dosage

The usual dosage for Ornidazol tablets is 500 mg to be taken orally twice daily for a specified duration as prescribed by a healthcare provider.

Indications

Ornidazol is indicated for the treatment of various infections caused by susceptible anaerobic bacteria and protozoa. It is commonly used in the management of infections of the gastrointestinal tract, gynecological infections, and certain types of skin infections.

Contraindications

Ornidazol tablets are contraindicated in patients with a history of hypersensitivity to ornidazole or other nitroimidazole derivatives. It should be used with caution in patients with a history of blood disorders or neurological disorders.

Directions

Ornidazol tablets should be taken with food to improve absorption and reduce the risk of gastrointestinal side effects. It is important to complete the full course of treatment as prescribed by the healthcare provider, even if symptoms improve before the course is completed.

Scientific Evidence

Ornidazol has been extensively studied for its efficacy in treating various infections. Research studies have demonstrated the effectiveness of ornidazole in the treatment of anaerobic bacterial infections and certain protozoal infections. The drug’s mechanism of action involves the inhibition of DNA synthesis in susceptible organisms, leading to their death.

Additional Information

Ornidazol tablets may cause side effects such as nausea, vomiting, and metallic taste in the mouth. It is important to inform the healthcare provider about any adverse reactions experienced during treatment. Patients should avoid consuming alcohol while taking ornidazole as it may cause disulfiram-like reactions.

Ornidazol is a valuable antimicrobial agent that offers broad-spectrum coverage against anaerobic bacteria and protozoa. Its convenient dosage regimen and proven efficacy make it a popular choice for healthcare providers in the management of various infections.

Clinical trials have shown Ornidazol to be comparable in effectiveness to other commonly used nitroimidazoles, with a favorable safety profile. Its well-established pharmacological actions make it a reliable option for the treatment of infections where anaerobic organisms are implicated.